Precision BioSciences Announces 2026 Annual Meeting Results and Incentive Plan Amendment

On May 21, 2026, Precision BioSciences, Inc. held its 2026 Annual Meeting of Stockholders. During the meeting, stockholders approved several key proposals, including the election of Melinda Brown and Geno Germano as Class I directors to serve until 2029. Stockholders also approved an amendment and restatement of the 2019 Incentive Award Plan, which increases the number of shares of Common Stock available for issuance by 3,800,000 shares. Additionally, a Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation was approved and filed, effective May 22, 2026. This amendment provides for the exculpation of certain officers as permitted under Delaware law, aligning the company's charter with recent legislative changes to limit personal liability for breaches of fiduciary duty. Other matters approved included the ratification of Deloitte & Touche LLP as the independent auditor for 2026 and the advisory approval of executive compensation. A total of approximately 86% of outstanding shares were represented at the meeting.